Myelofibrosis-Related Arthritis Successfully Treated with Hydroxyurea
A 62-year-old woman suffering from one-year lasting, nonerosive peripheral arthritides with general health impairment and high acute-phase reactant levels was admitted to rheumatology department. The patient had suffered from chronic polyarthralgia and a thrombocytosis had been discovered 9 years be...
Saved in:
| Main Authors: | Xavier Guillot, Marius Moldovan, Claire Vidon, Daniel Wendling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2014/869743 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffuse mucocutaneous hyperpigmentation related to hydroxyurea
by: Vishnu Sharma, et al.
Published: (2024-12-01) -
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study
by: Yi Zhang, et al.
Published: (2024-12-01) -
Real World Management of Cytopenias and Infections in Patients With Myelofibrosis Treated With Ruxolitinib
by: Liesl A. Butler, et al.
Published: (2025-04-01) -
Hemostasis in patients with primary myelofibrosis treated with ruxolitinib
by: O. G. Golovina, et al.
Published: (2024-11-01) -
Treatment Strategies Used in Treating Myelofibrosis: State of the Art
by: Massimo Martino, et al.
Published: (2024-10-01)